HomeCNSP • NASDAQ
add
CNS Pharmaceuticals Inc
Previous close
$6.07
Day range
$5.76 - $6.65
Year range
$4.93 - $221.94
Market cap
3.72M USD
Avg Volume
65.93K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.41M | -4.70% |
Net income | -2.37M | 6.16% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.41M | 4.71% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 12.13M | 713.23% |
Total assets | 14.51M | 487.54% |
Total liabilities | 1.38M | -79.55% |
Total equity | 13.12M | — |
Shares outstanding | 574.58K | — |
Price to book | 0.23 | — |
Return on assets | -42.63% | — |
Return on capital | -49.32% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -2.37M | 6.16% |
Cash from operations | -5.34M | -223.76% |
Cash from investing | — | — |
Cash from financing | 4.43M | 90.20% |
Net change in cash | -917.72K | -235.69% |
Free cash flow | -4.15M | -502.44% |
About
Founded
2017
Headquarters
Website
Employees
5
